PNPLA3 and liver disorder: Among others, we discovered novel associations for p.I148M in PNPLA3. This is a common gain-of-function missense allele increasing the risk for a range of liver phenotypes, which suggested that pharmaceutical inhibition of PNPLA3 could be a viable strategy to treat or prevent liver diseases.